Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

Bone Marrow Transplantation volume 41, pages 349–353 (2008)Cite this article

Abstract

Allogeneic hematopoietic cell transplantation (HCT) in patients with Hurler's syndrome can improve survival and ameliorate many aspects of Hurler's syndrome including neurologic decline and cardiac compromise. Unfortunately, the toxicity of traditional preparative regimens to organs affected by the syndrome may have deleterious effects. Additionally, despite the intensity of these regimens, achieving stable donor chimerism can be difficult. We report transplant outcomes following a reduced intensity, highly immunosuppressive preparative regimen consisting of alemtuzumab, fludarabine and melphalan prior to HCT in seven patients with Hurler's syndrome treated at two centers. Six patients received grafts from unrelated donors and one received a sibling donor graft. The preparative regimen was well tolerated. All patients had initial donor engraftment at 100 days; one patient had delayed loss of donor chimerism. There was no severe acute GVHD (no GI GVHD of grade II or more, no grade IV skin GVHD). Six of the seven children are surviving at a median of 1014 (726–2222) days post transplant. This reduced intensity preparative regimen has the potential to support engraftment and improve survival and outcome in patients with Hurler's syndrome undergoing HCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kolodny EH, Charria-Ortiz G . Storage diseases of the reticuloendothelial system. In: Nathan DG, Orkin SH, Ginsburg D, Look AT (eds). Nathan and Oski's Hematology of Infancy and Childhood, 6th edn. Saunders: Philadelphia, 2003, pp 1399–1454.

    Google Scholar 

  2. Peters C . Hematopoietic cell transplantation for storage diseases. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell Publishing Ltd.: Oxford, 2004, pp 1455–1470.

    Google Scholar 

  3. Krivit W . Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. Springer Semin Immunopathol 2004; 26: 119–132.

    Article  Google Scholar 

  4. Peters C, Shapiro EG, Krivit W . Hurler syndrome: past, present, and future. J Pediatr 1998; 133: 7–9.

    Article  CAS  PubMed  Google Scholar 

  5. Shih SL, Lee YJ, Lin SP, Sheu CY, Blickman JG . Airway changes in children with mucopolysaccharidoses. Acta Radiol 2002; 43: 40–43.

    Article  PubMed  Google Scholar 

  6. Fleming DR, Henslee-Downey PJ, Ciocci G, Romond EH, Marciniak E, Munn RK et al. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I. Pediatr Transplant 1998; 2: 299–304.

    CAS  PubMed  Google Scholar 

  7. Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894–4902.

    CAS  Google Scholar 

  8. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ et al. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998; 91: 2601–2608.

    CAS  Google Scholar 

  9. Strasser SI, McDonald GB . Gastrointestinal and hepatic complications. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell: Malden, MA, USA, 2004, pp 769–810.

    Google Scholar 

  10. Sullivan KM . Graft-vs-host disease. In: Blume KG, Forman SJ, Appelbaum FR (eds). Thomas' Hematopoietic Cell Transplantation, 3rd edn. Blackwell: Malden, MA, USA, 2004, pp 635–664.

    Google Scholar 

  11. Peters C, Shapiro EG, Krivit W . Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation. Pediatr Transplant 1998; 2: 250–253.

    CAS  PubMed  Google Scholar 

  12. Whitley CB, Belani KG, Chang PN, Summers CG, Blazar BR, Tsai MY et al. Long-term outcome of Hurler syndrome following bone marrow transplantation. Am J Med Genet 1993; 46: 209–218.

    Article  CAS  PubMed  Google Scholar 

  13. Meyers CA, Weitzner M, Byrne K, Valentine A, Champlin RE, Przepiorka D . Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation. J Clin Oncol 1994; 12: 820–826.

    Article  CAS  Google Scholar 

  14. Chou RH, Wong GB, Kramer JH, Wara DW, Matthay KK, Crittenden MR et al. Toxicities of total-body irradiation for pediatric bone marrow transplantation. Int J Radiat Oncol Biol Phys 1996; 34: 843–851.

    Article  CAS  PubMed  Google Scholar 

  15. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960–1969.

    Article  CAS  PubMed  Google Scholar 

  16. Urban C, Benesch M, Sykora KW, Schwinger W, Lackner H . Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia. Bone Marrow Transplant 2005; 35: 591–594.

    Article  CAS  PubMed  Google Scholar 

  17. Delgado J, Thomson K, Russell N, Ewing J, Stewart W, Cook G et al. Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. Blood 2006; 107: 1724–1730.

    Article  CAS  Google Scholar 

  18. Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345–352.

    Article  CAS  PubMed  Google Scholar 

  19. Phipps S, Mulhern R . Developmental outcome of unrelated donor bone marrow transplantation in children with Hurler syndrome. Blood 1997; 89: 732–734.

    CAS  PubMed  Google Scholar 

  20. Fujisaki G, Kami M, Kishi Y . Cord-blood transplants from unrelated donors in Hurler's syndrome. N Engl J Med 2004; 351: 506–507 author reply -7.

    Article  CAS  PubMed  Google Scholar 

  21. Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F et al. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant 2003; 31: 1105–1117.

    Article  CAS  PubMed  Google Scholar 

  22. Grigull L, Beilken A, Schrappe M, Das A, Luecke T, Sander A et al. Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). Bone Marrow Transplant 2005; 35: 265–269.

    Article  CAS  PubMed  Google Scholar 

  23. Klangsinsirikul P, Carter GI, Byrne JL, Hale G, Russell NH . Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. Blood 2002; 99: 2586–2591.

    Article  CAS  Google Scholar 

  24. Simpson D . T-cell depleting antibodies: new hope for induction of allograft tolerance in bone marrow transplantation? BioDrugs 2003; 17: 147–154.

    Article  CAS  PubMed  Google Scholar 

  25. Rebello P, Cwynarski K, Varughese M, Eades A, Apperley JF, Hale G . Pharmacokinetics of CAMPATH-1H in BMT patients. Cytotherapy 2001; 3: 261–267.

    Article  CAS  Google Scholar 

  26. Grewal SS, van Burik JA, Peters C . Secondary graft failure associated with parainfluenza virus infection following hematopoietic cell transplantation. Bone Marrow Transplant 2005; 35: 425.

    Article  CAS  PubMed  Google Scholar 

  27. Gassas A, Sung L, Doyle JJ, Clarke JT, Saunders EF . Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature. Bone Marrow Transplant 2003; 32: 213–215.

    Article  CAS  PubMed  Google Scholar 

  28. Kharbanda S, Panoskaltsis-Mortari A, Haddad IY, Blazar BR, Orchard PJ, Cornfield DN et al. Inflammatory cytokines and the development of pulmonary complications after allogeneic hematopoietic cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant 2006; 12: 430–437.

    Article  CAS  PubMed  Google Scholar 

  29. Drew B, Peters C, Rimell F . Upper airway complications in children after bone marrow transplantation. Laryngoscope 2000; 110: 1446–1451.

    Article  CAS  PubMed  Google Scholar 

  30. Kottaridis PD, Milligan DW, Chopra R, Chakraverty RK, Chakrabarti S, Robinson S et al. In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation. Cytotherapy 2001; 3: 197–201.

    Article  CAS  Google Scholar 

  31. Perez-Simon JA, Kottaridis PD, Martino R, Craddock C, Caballero D, Chopra R et al. Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood 2002; 100: 3121–3127.

    Article  CAS  Google Scholar 

  32. Hale G, Zhang MJ, Bunjes D, Prentice HG, Spence D, Horowitz MM et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection. Blood 1998; 92: 4581–4590.

    CAS  Google Scholar 

  33. Grewal SS, Wynn R, Abdenur JE, Burton BK, Gharib M, Haase C et al. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 2005; 7: 143–146.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA

    M D Hansen, A H Filipovich, S M Davies, P Mehta, J Bleesing & S Jodele

  2. Division of Pediatric Hematology/Oncology, St Louis Children's Hospital, St Louis, MO, USA

    R Hayashi, Y Barnes & S Shenoy

Authors
  1. M D Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A H Filipovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S M Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Bleesing
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Jodele
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Hayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Y Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Shenoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M D Hansen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hansen, M., Filipovich, A., Davies, S. et al. Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 41, 349–353 (2008). https://doi.org/10.1038/sj.bmt.1705926

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705926

Keywords

This article is cited by

Search

Advanced search

Quick links